Lynparza Approved for Advanced Ovarian Cancer

FRIDAY, Dec. 19, 2014 (HealthDay News) -- Lynparza (olaparib) has been approved by the U.S. Food and Drug Administration to treat advanced ovarian cancer associated with defective BRCA genes, the agency said Friday in a news release.

FDA Approves First in New Class of Drugs for Advanced Ovarian Cancer

FRIDAY, Dec. 19, 2014 (HealthDay News) -- The U.S. Food and Drug Administration has approved a new drug to treat advanced ovarian cancer, along with a test to identify patients eligible to receive the drug.

Could Bacteria Play a Role in Colon Cancer?

FRIDAY, Dec. 19, 2014 (HealthDay News) -- Dense bunches of bacteria called biofilms can be found on most colon polyps and cancers, a new study finds.

Cancer Treatment Costs Weigh Heavily on Patients, Study Finds

FRIDAY, Dec. 19, 2014 (HealthDay News) -- The cost of cancer treatment can cause financial stress that threatens patients' well-being, a new study finds.

Common Painkillers May Help Prevent Certain Skin Cancers, Study Finds

THURSDAY, Dec. 18, 2014 (HealthDay News) -- Common painkillers, including ibuprofen, might slightly reduce your risk of developing a form of skin cancer, researchers say.

Global Life Expectancy Continues to Climb

WEDNESDAY, Dec. 17, 2014 (HealthDay News) -- People around the world are living much longer than they did a few decades ago, a new study indicates.

Flying Time Could Raise Skin Cancer Risks for Pilots

WEDNESDAY, Dec. 17, 2014 (HealthDay News) -- Airline pilots get as much exposure to cancer-causing UV rays in an hourlong flight as they would during 20 minutes in a tanning bed, new research finds.

When the Cancer Patient Is a Pet You Love

FRIDAY, Dec. 12, 2014 (HealthDay News) -- The scourge of cancer can strike peoples' four-legged friends, too, and an expert offers tips to spot the disease early so treatments can work best.

No Link Between Migraine, Breast Cancer Risk, Study Says

FRIDAY, Dec. 12, 2014 (HealthDay News) -- A large, new study should reassure the millions of American women who have migraine: The debilitating headaches don't raise the risk for breast cancer.

Cyramza Approval Expanded to Include Non-Small Lung Cancer

FRIDAY, Dec. 12, 2014 (HealthDay News) -- U.S. Food and Drug Administration approval of the anti-cancer drug Cyramza (ramucirumab) has been expanded to include aggressive non-small cell lung cancer (NSCLC), the agency said Friday.